Journal of Acupuncture Research

  • 제39권1호
  • /
  • Pages.49-52
  • /
  • 2022
  • /
  • 2586-288X(pISSN)
  • /
  • 2586-2898(eISSN)
대한침구의학회 (Korean Acupuncture & Moxibustion Medicine Society)
권호 표지
DOI QR코드

DOI QR Code

Comprehensive Korean Medicine Treatment for Benign Essential Blepharospasm in a Patient Responding Poorly to Botulinum Toxin Treatment

  • Ha, Seojung (Department of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Kim, Sung A (Department of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Lee, Suji (Department of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Choi, Sungwoon (Department of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Lee, Sanghoon (Department of Medical Education, College of Korean Medicine, Kyung Hee University)
  • 투고 : 2021.10.21
  • 심사 : 2021.11.29
  • 발행 : 2022.02.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Benign essential blepharospasm (BEB) is a condition/disease which involves involuntary muscle contractions causing the eye to repetitively close, making it impossible for the patient to perform daily activities. This study reports Korean medicine treatment of a rare case BEB in a 34-year-old male patient whose symptoms showed minimal improvement following botulinum toxin injection (the standard treatment). Acupuncture, pharmacopuncture, and herbal medicine treatment for 11 days resulted in clinical improvement for all symptoms as assessed by using the Jankovic Rating Scale, Blepharospasm Disability Index, numerical rating scale, duration of spasms lasting more than 1 hour per day, and number of spasms lasting less than 1 minute per day. This case report suggests that comprehensive Korean medicine treatment could be a treatment option for BEB in patients who do not respond well to botulinum toxin injection.

키워드

참고문헌

  1. Hwang CJ, Eftekhari K. Benign Essential Blepharospasm: What We Know and What We Don't. Int Ophthalmol Clin 2018;58:11-24. https://doi.org/10.1097/IIO.0000000000000207
  2. Ababneh OH, Cetinkaya A, Kulwin DR. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm. Clin Exp Ophthalmol 2014;42:254-261. https://doi.org/10.1111/ceo.12165
  3. Sun Y, Tsai P-J, Chu C-L, Huang W-C, Bee Y-S. Epidemiology of benign essential blepharospasm: A nationwide population-based retrospective study in Taiwan. PLoS One 2018;13:e0209558. https://doi.org/10.1371/journal.pone.0209558
  4. Anwar MS, Zafar H. Eff icacy of botulinum toxin in benign essential Blepharospasm: Desirable & undesirable effects. Pak J Med Sci 2013;29:1389-1393.
  5. Keith DJ, Eshleman AJ, Janowsky A. Melittin stimulates fatty acid release through non-phospholipase-mediated mechanisms and interacts with the dopamine transporter and other membrane-spanning proteins. Eur J Pharmacol 2011;650:501-510. https://doi.org/10.1016/j.ejphar.2010.10.023
  6. Keith DJ, Wolfrum K, Eshleman AJ, Janowsky A. Melittin initiates dopamine transporter internalization and recycling in transfected HEK-293 cells. Eur J Pharmacol 2012;690:13-21. https://doi.org/10.1016/j.ejphar.2012.05.020
  7. Cheng F, Ma C, Wang X, Zhai C, Wang G, Xu X et al. Effect of traditional Chinese medicine formula Sinisan on chronic restraint stress-induced nonalcoholic fatty liver disease: A rat study. BMC Complementary and Alternative Medicine 2017;17:203. https://doi.org/10.1186/s12906-017-1707-2